UTHR
United Therapeutics Corporation - Common Stock (UTHR)
$82
About United Therapeutics Corporation - Common Stock (UTHR)
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Details
Daily high
$497.70
Daily low
$491.26
Price at open
$497.70
52 Week High
$609.35
52 Week Low
$409.07
Market cap
21.2B
Dividend yield
-
Volume
45,652
Avg. volume
702,936
P/E ratio
17.69
United Therapeutics Corporation - Common Stock News
Details
Daily high
$497.70
Daily low
$491.26
Price at open
$497.70
52 Week High
$609.35
52 Week Low
$409.07
Market cap
21.2B
Dividend yield
-
Volume
45,652
Avg. volume
702,936
P/E ratio
17.69